Latest / Denver Regenerative Medicine

What is Retatrutide?
Retatrutide is a triple-hormone weight loss medication targeting GLP-1, GIP, and glucagon, but it's still investigational and not FDA approved. Learn what's actually available today: tirzepatide, a dual GIP/GLP-1 agonist offered through Denver Regenerative Medicine's physician-supervised weight loss programs.
Visit: https://denverregenerativemedicine.com/tirzepatide-weight-loss-injections/
#Retatrutide #GLP1 #Tirzepatide #DenverWeightLoss #MetabolicHealth
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.